Retifanlimab Combination Signals a New Era of Chemoimmunotherapy in Frontline Advanced Anal Cancer | OncLive Richard D. Kim, MD, discusses how positive results from PODIUM-303 exemplify and support the shift towards chemoimmunotherapy regimens in frontline SCAC.

Richard D. Kim, MD, of @moffittnews.bsky.social, breaks down the evolving role of chemoimmunotherapy in the frontline management of advanced SCAC and shares how the integration of retifanlimab has affected the treatment paradigm #ancsm #oncology www.onclive.com/view/retifan...

Home-Based Anal Cancer Screening Offers Cost-Effective Alternative, Increases Screening Rate Investigators sought to determine the cost-effectiveness of home- versus clinic-based anal cancer screening for increasing uptake among sexual and gender minorities.

Home-based #analcancer screening appears to be a cost-effective option for increasing screening rates among sexual and gender minority individuals. Published in @jamanetworkopen.com.

https://bit.ly/4sX4Kbj

#cancerScreening #ancsm #gicsm

Happening now at #GI26: Rapid Oral Abstract Session C: Cancers of the Colon, Rectum, and Anus. #crcsm #ancsm meetings.asco.org/meetings/202...

This session includes a press program abstract on GLP-1 receptor agonists as potential cancer prevention Tx strategy: www.asco.org/about-asco/p...

Good morning from #GI26! Join us for posters & a complimentary continental breakfast from 7-8 AM (PT). 🥐☕ Sip your coffee and view the posters and trials in progress posters on science & findings re: cancers of the colon, rectum & anus. asco.org/gi-program

#crcsm #ancsm

Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment Options [Mar 30, 2020] Bitzer et al. @ASCO_pubs ow.ly/MuHP30qAEI0 #PrecisionMedicine #ancsm #crcsm #esocsm #hpbcsm #pancsm #sbcsm #stcsm n=96, Apr 2016 - Feb 2018